| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
|---|---|---|---|---|---|---|
| C56644363478 |
|
— |
SparfloxacinLactate - 98% |
0 | C19H22F2N4O3·C3H6O3 | |
| C5664436355661904 |
|
18741-85-0 |
(R)-(+)-2,2'-Diamino-1,1'-binaphthalene - 98% |
0 | C20H16N2 | |
| C5664436355661903 |
|
16037-91-5 |
Sodium Stibogluconate - 98% |
0 | C12H37Na3O27Sb2 | |
| C56644363556619021 |
|
193149-74-5 |
WST-8 - 99% |
0 | C20H15N6NaO11S2 | |
| C5664436355661902 |
|
180288-69-1 |
Trastuzumab - 98% |
0 | — | |
| C5664436355661901 |
|
19798-81-3 |
2-Amino-6-bromopyridine - 98% |
0 | C5H5BrN2 | |
| C566443635566189 |
|
90213-66-4 |
2,4-DICHLORO-7H-PYRROLO2,3-DPYRIMIDINE - 98% |
0 | C6H3Cl2N3 | |
| C5664436355661851311 |
|
831-61-8 |
Ethyl gallate - 99% |
0 | C9H10O5 | |
| C56644363556618513 |
|
1445085-77-7 |
RuPhos Pd G3 - 98% |
0 | C43H57NO5PPdS- | |
| C56644363556618512 |
|
479094-62-7 |
DI-TERT-BUTYLMETHYLPHOSPHONIUM TETRAFLUOROBORATE - 98% |
0 | C9H22BF4P | |
| C56644336 |
|
178601-88-2 |
(Z)-Cefdinir - 95% |
0 | C14H13N5O5S2 | |
| C56644335 |
|
943609-66-3 |
Vedolizumab - 98% |
0 | — | |
| C566443635566185 |
|
697739-03-0 |
Methyl 5-fluoro-2-methyl-3-nitrobenzoate - 98% |
0 | C9H8FNO4 | |
| C566443635566184 |
![Pyrrolo[2,3-d]pyrimidin-4-ol](/image/19511)
|
3680-71-5 |
Pyrrolo[2,3-d]pyrimidin-4-ol - 98% |
0 | C6H5N3O | |
| C566443635566183 |
|
7274-88-6 |
D-Lysine hydrochloride - 98% |
0 | C6H15ClN2O2 | |
| C566443635566182 |
|
93-07-2 |
3,4-Dimethoxybenzoic acid - 99% |
0 | C9H10O4 | |
| C56644363556619 |
|
3163-76-6 |
1,3,5-Benzenetricarboxaldehyde - 98% |
0 | C9H6O3 | |
| C566443635566181 |
|
38041-19-9 |
4-Aminotetrahydropyran - 98% |
0 | C5H11NO | |
| C56644363556618 |
|
321921-71-5 |
Butyldi-1-adamantylphosphine - 98% |
0 | C24H39P | |
| C56644363556617 |
|
131211-27-3 |
DI-1-ADAMANTYLPHOSPHINE - 98% |
0 | C20H31P | |
